CVE-2021-26726
CVE-2021-26726 is a high-severity vulnerability in Valmet Dna with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-330.
Key facts
- Severity: High (CVSS 3.x base score 8.8)
- CVSS v2: 8.3
- EPSS exploit prediction: 1% (63rd percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-330
- Affected product: Valmet Dna
- Published:
- Last modified:
Description
A remote code execution vulnerability affecting a Valmet DNA service listening on TCP port 1517, allows an attacker to execute commands with SYSTEM privileges This issue affects: Valmet DNA versions from Collection 2012 until Collection 2021.
Frequently asked questions
- What is CVE-2021-26726?
- A remote code execution vulnerability affecting a Valmet DNA service listening on TCP port 1517, allows an attacker to execute commands with SYSTEM privileges This issue affects: Valmet DNA versions from Collection 2012 until Collection 2021.
- How severe is CVE-2021-26726?
- CVE-2021-26726 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
- Is CVE-2021-26726 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (63rd percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2021-26726?
- CVE-2021-26726 affects Valmet Dna. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2021-26726?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- When was CVE-2021-26726 published?
- CVE-2021-26726 was published on 2022-02-16 and last updated on 2026-06-17.
References
- https://www.nozominetworks.com/labs/vulnerability-advisories/cve-2021-26726/
- https://www.valmet.com/about-us/research-and-development/vulnerabilityadvisories/
Affected products (1)
- cpe:2.3:a:valmet:dna:*:*:*:*:*:*:*:*
More vulnerabilities in Valmet Dna
- CVE-2025-15577 — High (CVSS 7.5): An unauthenticated attacker can exploit this vulnerability by manipulating URL to achieve arbitrary file read…
All CVEs affecting Valmet Dna →
Other CWE-330 (Use of Insufficiently Random Values) vulnerabilities
- CVE-2023-22601 — Critical (CVSS 10.0): InHand Networks InRouter 302, prior to version IR302 V3.5.56, and InRouter 615, prior to version…
- CVE-2026-25072 — Critical (CVSS 9.8): XikeStor SKS8310-8X Network Switch firmware versions 1.04.B07 and prior contain a predictable session identifier…
- CVE-2026-27755 — Critical (CVSS 9.8): SODOLA SL902-SWTGW124AS firmware versions through 200.1.20 contain a weak session identifier generation vulnerability…
- CVE-2026-27637 — Critical (CVSS 9.8): FreeScout is a free help desk and shared inbox built with PHP's Laravel framework. Prior to version 1.8.206,…
- CVE-2025-64097 — Critical (CVSS 9.8): NervesHub is a web service that allows users to manage over-the-air (OTA) firmware updates of devices in the field. A…
- CVE-2025-4607 — Critical (CVSS 9.8): The PSW Front-end Login & Registration plugin for WordPress is vulnerable to Privilege Escalation in all versions up…
Browse all CWE-330 (Use of Insufficiently Random Values) vulnerabilities →